Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Inge Johnsen

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Cancer Discovery|July 7, 2021
Pharmacologic Activation of p53 Triggers Viral Mimicry Response Thereby Abolishing Tumor Immune Evasion and Promoting Antitumor ImmunityXiaolei Zhou, Madhurendra Singh, Gema Sanz Santos, et al.
Cancer Letters|September 22, 2024
The ROCK-1/2 inhibitor RKI-1447 blocks N-MYC, promotes cell death, and emerges as a synergistic partner for BET inhibitors in neuroblastomaAdena Pepich, Conny Tümmler, Sara Abu Ajamieh, et al.
Cell Reports|July 12, 2016
Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs Impacts Neural Differentiation and Survival in Neuroblastoma PatientsDiogo Ribeiro, Marcus D R Klarqvist, Ulrica K Westermark, et al.
Cell Death & Disease|April 19, 2025
Targeted inhibition of WIP1 and histone H3K27 demethylase activity synergistically suppresses neuroblastoma growthDiana Treis, Kristina Ihrmark Lundberg, Nicola Bell, et al.
International Journal of Cancer|May 11, 2013
Frequent detection of human cytomegalovirus in neuroblastoma: a novel therapeutic target?Nina Wolmer-Solberg, Ninib Baryawno, Afsar Rahbar, et al.
Scientific Reports|April 19, 2017
Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluationEmma Sandén, Cecilia Dyberg, Cecilia Krona, et al.
Cell Death & Disease|October 7, 2021
Inhibition of the ubiquitin-proteasome system by an NQO1-activatable compoundTatiana A Giovannucci, Florian A Salomons, Martin Haraldsson, et al.
The Journal of Clinical Investigation|September 28, 2011
Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic targetNinib Baryawno, Afsar Rahbar, Nina Wolmer-Solberg, et al.
Frontiers in Oncology|December 28, 2020
Hodgkin Lymphoma Monozygotic Triplets Reveal Divergences in DNA Methylation SignaturesChuanyou Xia, Thale Kristin Olsen, A Ali Zirakzadeh, et al.
Cancer Research|December 29, 2020
Subcellular Distribution of p53 by the p53-Responsive lncRNA <i>NBAT1</i> Determines Chemotherapeutic Response in NeuroblastomaSanhita Mitra, Somsundar Veppil Muralidharan, Mirco Di Marco, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Cancer Discovery|July 7, 2021
Pharmacologic Activation of p53 Triggers Viral Mimicry Response Thereby Abolishing Tumor Immune Evasion and Promoting Antitumor ImmunityXiaolei Zhou, Madhurendra Singh, Gema Sanz Santos, et al.
Cancer Letters|September 22, 2024
The ROCK-1/2 inhibitor RKI-1447 blocks N-MYC, promotes cell death, and emerges as a synergistic partner for BET inhibitors in neuroblastomaAdena Pepich, Conny Tümmler, Sara Abu Ajamieh, et al.
Cell Reports|July 12, 2016
Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs Impacts Neural Differentiation and Survival in Neuroblastoma PatientsDiogo Ribeiro, Marcus D R Klarqvist, Ulrica K Westermark, et al.
Cell Death & Disease|April 19, 2025
Targeted inhibition of WIP1 and histone H3K27 demethylase activity synergistically suppresses neuroblastoma growthDiana Treis, Kristina Ihrmark Lundberg, Nicola Bell, et al.
International Journal of Cancer|May 11, 2013
Frequent detection of human cytomegalovirus in neuroblastoma: a novel therapeutic target?Nina Wolmer-Solberg, Ninib Baryawno, Afsar Rahbar, et al.
Scientific Reports|April 19, 2017
Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluationEmma Sandén, Cecilia Dyberg, Cecilia Krona, et al.
Cell Death & Disease|October 7, 2021
Inhibition of the ubiquitin-proteasome system by an NQO1-activatable compoundTatiana A Giovannucci, Florian A Salomons, Martin Haraldsson, et al.
The Journal of Clinical Investigation|September 28, 2011
Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic targetNinib Baryawno, Afsar Rahbar, Nina Wolmer-Solberg, et al.
Frontiers in Oncology|December 28, 2020
Hodgkin Lymphoma Monozygotic Triplets Reveal Divergences in DNA Methylation SignaturesChuanyou Xia, Thale Kristin Olsen, A Ali Zirakzadeh, et al.
Cancer Research|December 29, 2020
Subcellular Distribution of p53 by the p53-Responsive lncRNA <i>NBAT1</i> Determines Chemotherapeutic Response in NeuroblastomaSanhita Mitra, Somsundar Veppil Muralidharan, Mirco Di Marco, et al.
Pageof 9